Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 10 (Search time: 0.004 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Doxorubicin overcomes resistance to drozitumab by antagonizing inhibitor of apoptosis proteins (IAPS)Zinonos, I.; Labrinidis, A.; Liapis, V.; Hay, S.; Panagopoulos, V.; Denichilo, M.; Ponomarev, V.; Ingman, W.; Atkins, G.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2011Myeloma-induced alloreactive T cells arising in myeloma-infiltrated bones include double-positive CD8⁺CD4⁺ T cells: evidence from myeloma-bearing mouse modelFreeman, L.; Lam, A.; Petcu, E.; Smith, R.; Salajegheh, A.; Diamond, P.; Zannettino, A.; Evdokiou, A.; Luff, J.; Wong, P.; Khalil, D.; Waterhouse, N.; Vari, F.; Rice, A.; Catley, L.; Hart, D.; Vuckovic, S.
2014Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancerZinonos, I.; Luo, K.; Labrinidis, A.; Liapis, V.; Hay, S.; Panagopoulos, V.; Denichilo, M.; Ko, C.; Yue, G.; Lau, C.; Ingman, W.; Ponomarev, V.; Atkins, G.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2016Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine modelsLiapis, V.; Zinonos, I.; Labrinidis, A.; Hay, S.; Ponomarev, V.; Panagopoulos, V.; Zysk, A.; DeNichilo, M.; Ingman, W.; Atkins, G.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2004The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitroPan, B.; To, L.; Farrugia, A.; Findlay, D.; Green, J.; Gronthos, S.; Evdokiou, A.; Lynch, K.; Atkins, G.; Zannettino, A.
2001Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of boneAtkins, G.; Bouralexis, S.; Haynes, D.; Graves, S.; Geary, S.; Evdokiou, A.; Zannettino, A.; Hay, S.; Findlay, D.
2009Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone lossDiamond, P.; Labrinidis, A.; Martin, S.; Farrugia, A.; Gronthos, S.; To, L.; Fujii, N.; O'Loughlin, P.; Evdokiou, A.; Zannettino, A.
2003RANKL expression is related to the differentiation state of human osteoblastsAtkins, G.; Kostakis, P.; Pan, B.; Farrugia, A.; Gronthos, S.; Evdokiou, A.; Harrison, K.; Findlay, D.; Zannettino, A.
2017Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancerZysk, A.; DeNichilo, M.; Panagopoulos, V.; Zinonos, I.; Liapis, V.; Hay, S.; Ingman, W.; Ponomarev, V.; Atkins, G.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2017Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcomaLiapis, V.; Zysk, A.; DeNichilo, M.; Zinonos, I.; Hay, S.; Panagopoulos, V.; Shoubridge, A.; Difelice, C.; Ponomarev, V.; Ingman, W.; Atkins, G.; Findlay, D.; Zannettino, A.; Evdokiou, A.